Suchergebnisse - "DiStefano, Michael J"

PubPharm (40)

1

Assessing clinical benefit in the Medicare Drug Price Negotiation Program : A 2-step approach for improving transparency, consistency, and meaningful patient engagement

enthalten in: Journal of managed care & specialty pharmacy | 2024

von DiStefano, M. | Zemplenyi, A. | McQueen, R.

2

The ethical canary : narrow reflective equilibrium as a source of moral justification in healthcare priority-setting

enthalten in: Journal of medical ethics | 2024

von Charlton, V. | DiStefano, M.

3

Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in Medicaid

enthalten in: PharmacoEconomics | 2024

von Zemplenyi, A. | Leonard, J. | DiStefano, M. | +5

4

Alternative approaches to measuring value : an update on innovative methods in the context of the United States Medicare drug price negotiation program

enthalten in: Expert review of pharmacoeconomics & outcomes research | 2024

von DiStefano, M. | Zemplenyi, A. | Anderson, K. | +3

5

Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in Medicaid

enthalten in: PharmacoEconomics | 2023

von Zemplenyi, A. | Leonard, J. | DiStefano, M. | +5

6

Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price Negotiations

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2023

von DiStefano, M. | Levy, J. | Odouard, I. | +1

7

False or Misleading Claims in Online Direct-to-Consumer Ketamine Advertising in Maryland

enthalten in: JAMA network open | 2023

von Crane, M. | DiStefano, M. | Moore, T.

8

Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2023

von Anderson, K. | DiStefano, M. | Liu, A. | +3

9

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance

enthalten in: JAMA health forum | 2023

von DiStefano, M. | Kang, S. | Parasrampuria, S. | +1

10

The Value of Explicit, Deliberative, and Context-Specified Ethics Analysis for Health Technology Assessment : Evidence From a Novel Approach Piloted in South Africa

enthalten in: Value in health regional issues | 2023

von Krubiner, C. | Tugendhaft, A. | DiStefano, M. | +7